PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-12-27

Date Title Company
27-Dec-2023 Flow Diverters Market Poised to Reach USD 1.0 Billion by 2031 | Fueled by the Surge in the Research Activities which Enhances Demand of Flow Diverters The Wire Times
27-Dec-2023 Advancements in Wound Care Technology Propelling Surgical Dressing Market to Surpass USD 2.7 billion by 2031, Report The Wire Times
27-Dec-2023 Basic Chemicals Market - Trends, Share [Latest] & Forecast TechSci Research Europe GmbH
27-Dec-2023 Small Molecule Innovator CDMO Market Targets a Staggering US$89.43 Billion Valuation in 2033-FMI Study MARKITWIRED
27-Dec-2023 Primary Hyperoxaluria Treatment Market Poised for Striking 8.6% CAGR Growth from 2023 to 2033-FMI Study MARKITWIRED
27-Dec-2023 Latin America Hypodermic Syringes and Needles Market Aims High with an Ambitious US$360.78 Million Projection by 2033-FMI Study MARKITWIRED
27-Dec-2023 Dental Practice Management Software Market Targets a Striking US$6.74 Billion Valuation by 2033-FMI Study MARKITWIRED
27-Dec-2023 United States Concierge Medicine Market Anticipates a Noteworthy US$17.97 Billion Valuation by 2033-FMI Study MARKITWIRED
27-Dec-2023 Isocitrate Dehydrogenase (IDH) Inhibitors Market Secures a Remarkable Valuation of US$39.16 Billion in 2033-FMI Study MARKITWIRED
27-Dec-2023 Lumbosacral Radicular Pain Management Market Aims for a Striking US$1.4 Billion Valuation by 2033-FMI Study MARKITWIRED
27-Dec-2023 Barrett’s Esophagus with Dysplasia Treatment Market Envisions 5.3% CAGR Growth from 2023 to 2033-FMI Study MARKITWIRED
27-Dec-2023 Formycon announces EMA acceptance of the MAA for FYB203, a biosimilar candidate to Eylea® (Aflibercept) Formycon AG
27-Dec-2023 IRLAB Extends CEO Appointment AccessWire
27-Dec-2023 Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA AccessWire
27-Dec-2023 Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA Kuros Biosciences AG
27-Dec-2023 Global Hyperglycemia Treatment Industry is anticipated to witness a consistent 12.3% CAGR growth from 2023 to 2033 | FMI MARKITWIRED
27-Dec-2023 Global Hypopituitarism Diagnostics Industry is set to attain US$ 447.41 Million by 2033 | FMI MARKITWIRED
27-Dec-2023 Global Takotsubo Syndrome Therapeutics Industry is expected to touch US$ 2.85 Billion by 2033, as suggested by the FMI Report MARKITWIRED
27-Dec-2023 Global Prinzmetal Angina Therapeutics Industry is poised to reach a staggering US$ 17.2 Billion by 2033 as per the FMI Report MARKITWIRED
27-Dec-2023 Global Pituitary Stalk Interruption Syndrome Treatment Industry is expected to grow at a value of 3.5% CAGR as outlined in the FMI Study for the period 2023-2033 MARKITWIRED